# Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction

> **NCT00802893** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 3 (actual)

## Conditions studied

- Isolated Systolic Hypertension
- Endothelial Dysfunction

## Interventions

- **DRUG:** 6R-BH4
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00802893
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** We were unable to recruit any subjects into this study so no subjects completed the protocol. Therefore, we are unable to provide any conclusions.
- **Last updated:** 2017-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00802893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00802893, "Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00802893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*